$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How Brivaracetam was developed and where the drug comes from
2026-02-01 22:25:32
Check Details
Is fostatinib/fotantinib a targeted drug?
2026-02-01 22:25:32
Check Details
Can you stop taking Seputinib/Serpatinib (Ruitu) once you take it?
2026-02-01 22:25:32
Check Details
Application of pembrolizumab combined with lenvatinib/lenvatinib (Lenvima) in nccRCC
2026-02-01 22:25:32
Check Details
Is fezolinetant included in medical insurance?
2026-02-01 22:25:32
Check Details
Is Besudil/Yilaike considered a hormonal drug?
2026-02-01 22:25:32
Check Details
How much does a box of Brivaracetam tablets cost? Market reference
2026-02-01 22:25:32
Check Details
What is the specific drug policy for veentuzumab/besifux?
2026-02-01 22:25:32
Check Details
What is the difference between Capisetide/Tunicate and Inarisep
2026-02-01 22:25:32
Check Details
What’s the latest news about Napavir/Salanka?
2026-02-01 22:25:32
Check Details
The latest domestic sales price of Rucaparib
2026-02-01 22:25:32
Check Details
Advantages of Sotatercept-Winrevair over other PAH drugs
2026-02-01 22:25:32
Check Details
1
2
...
2089
2090
2091
2092
2093
2094
2095
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
2
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
3
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
4
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
5
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
10
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
11
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
12
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment